Report Scope:
The report provides a comprehensive summary of the Non-injectable insulin market, along with detailed profiles of key market players that include revenue product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. The report discusses strategies adopted by emerging market players, with recommendations for new market entrants. This research study discusses historical, current and potential market size. The report will help market players and new entrants make informed decisions about the production and export of goods and services. Organizations, distributors and exporters should find the information about market development and trends useful. The study segments the market according to applications and end-uses. Geographical market analysis is provided for all major segments.
The Report Includes:
- An overview of the global market for non-injectable insulin
- Analyses of market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information on recent major technical advances in different forms of non-injectable insulin
- A look at the key areas of growth and adoption rate of non-injectable insulin among both commercial customers and regulatory authorities
- Examination of strategies of the major players in the market and the impact of new technological developments
Table of Contents
Samples
LOADING...
Companies Mentioned
- Access Pharmaceuticals Inc. (Abeona Therapeutics Inc.)
- Aerami Therapeutics
- Biocon Ltd.
- Biodel Inc. (Albireo Ltd.)
- Bionova Lifesciences
- Boston Therapeutics Inc.
- Coromed Inc.
- Diabetology Ltd.
- Diasome Pharmaceuticals Inc.
- Emisphere Technologies Inc.
- Generex Biotechnology Corp.
- Midatech Pharma Plc
- Oramed Pharmaceuticals Inc.
- Rani Therapeutics
- Shreya Life Sciences Pvt. Ltd.
